论文部分内容阅读
目的 探讨三种方法联合治疗非破裂输卵管妊娠的可能性 ,以期降低输卵管妊娠的手术率。方法 米非司酮 5 0mgtidpo ,共 5d ,甲氨碟呤 (MTX) 5 0～ 60mgimST视绒毛膜促性腺激素水平 (HCG)而定 ,服宫外孕 1号方加减。单用米非司酮的病人设为对照组。结果 MTX中药 ,米非司酮成功率 95 45 % (63 /66)明显高于对照组 5 4 3 8% (3 1/5 7)治疗期间密切观察HCG腹痛及出血情况。结论 MTX米非司酮中药联合治疗非破裂性输卵管妊娠安全有效 ,适应于生命体征稳定 ,无明显腹痛 ,无胎心动者。
Objective To explore the possibility of combining three methods in the treatment of non-ruptured tubal pregnancy in order to reduce the operation rate of tubal pregnancy. Methods Mifepristone 50mgtidpo, for 5 days, methotrexate (MTX) 50 ~ 60mgimST depending on the level of chorionic gonadotropin (HCG), taking ectopic pregnancy on the 1st side addition and subtraction. Patients with mifepristone alone were set as controls. Results The success rate of MTX Chinese medicine and mifepristone was 95 45% (63/66), which was significantly higher than that of the control group (43%, 37%). HCG abdominal pain and bleeding were closely observed during the treatment. Conclusion MTX mifepristone combination treatment of non-ruptured tubal pregnancy is safe and effective, adapted to the stability of vital signs, no obvious abdominal pain, no fetal heartbeat.